Eagle Pharma And Teikoku Pharma Won FDA Approval of Docetaxel Injection, First and Only Alcohol-Free Formulation October 14, 2016 breast cancer Docetaxel Injection Eagle Pharmaceuticals gastric adenocarcinoma non-small cell lung cancer prostate cancer +